My
Myokardia (BMS)
S San Francisco CAFounded 2012150 employees
Private CapbiotechAcquiredCardiology
Platform: Mavacamten HCM
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MYO-4326 | MYO-4326 | Phase 2/3 | 1 | BET | EoE | ||
| Liraratamab | MYO-7250 | Approved | 1 | FcRn | ALSMDD | ||
| MYO-9608 | MYO-9608 | NDA/BLA | 1 | APOC3 | Ewing Sarcoma |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)